日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Safety and immunogenicity of heterologous boosting with orally administered aerosolized bivalent adenovirus type-5 vectored COVID-19 vaccine and B.1.1.529 variant adenovirus type-5 vectored COVID-19 vaccine in adults 18 years and older: a randomized, double blinded, parallel controlled trial

一项随机、双盲、平行对照试验,评估了18岁及以上成年人口服气溶胶二价腺病毒5型载体COVID-19疫苗和B.1.1.529变异株腺病毒5型载体COVID-19疫苗进行异源加强免疫的安全性和免疫原性。

Xu, Jia-Wei; Wang, Bu-Sen; Gao, Ping; Huang, Hai-Tao; Wang, Fei-Yu; Qiu, Wei; Zhang, Yuan-Yuan; Xu, Yu; Gou, Jin-Bo; Yu, Lin-Ling; Liu, Xuan; Wang, Rui-Jie; Zhu, Tao; Hou, Li-Hua; Wang, Qing-

Fear stress promotes glioma progression through inhibition of ferroptosis by enhancing FSP1 stability

恐惧压力通过增强 FSP1 稳定性抑制铁死亡,从而促进神经胶质瘤进展

Chaojie Bu #, Sen Hu #, Jinliang Yu, Nianxuan Li, Jianjun Gu, Zhiyuan Sheng, Zhaoyue Yan, Xingyao Bu

P359 Influence of the nature of immunosuppressive therapy in patients with inflammatory bowel diseases on the level of immunoglobulins G after a Coronavirus Infection

P359 免疫抑制疗法的性质对炎症性肠病患者冠状病毒感染后免疫球蛋白G水平的影响

Zhu, Feng-Cai; Li, Yu-Hua; Guan, Xu-Hua; Hou, Li-Hua; Wang, Wen-Juan; Li, Jing-Xin; Wu, Shi-Po; Wang, Bu-Sen; Wang, Zhao; Wang, Lei; Jia, Si-Yue; Jiang, Hu-Dachuan; Wang, Ling; Jiang, Tao; Hu, Yi; Gou, Jin-Bo; Xu, Sha-Bei; Xu, Jun-Jie; Wang, Xue-Wen; Wang, Wei; Chen, Wei; Butler, James J; Rizlan, Muhammad Raziq Mohammed; Azam, Mohammad T; Campbell, Hilary T; Kennedy, John G; Manel, Boudokhane; Hiba, Ben Ayed; Sarra, Ben Yaacoub; Rym, Bourguiba; Zeineb, Teyeb; Mariem, Ayari; Taieb, Jomni; Imen, Abdelaali; Syrine, Belakhal; Hedi, Dougui Mohamed; Bhimani, Rohan; Lubberts, Bart; Hagemeijer, Noortje; Zhao, John Z; Saengsin, Jirawat; Sato, Go; Waryasz, Gregory R; DiGiovanni, Christopher W; Guss, Daniel; Chinnakannu, Karthikeyan; Abyar, Eildar; McKissack, Haley M; Pinto, Martim; Jha, Aaradhana J; Moraes, Leonardo V; Naranje, Sameer M; Shah, Ashish B; Knyazev, O; Kagramanova, A; Lishchinskaya, A; Noskova, K; Chernova, M; Shkurko, T; Veselov, A; Kulakov, D; Li, I; Parfenov, A

Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial

一项针对18岁及以上健康成年人的随机、双盲、安慰剂对照的II期临床试验,评估了重组5型腺病毒载体COVID-19疫苗的免疫原性和安全性。

Zhu, Feng-Cai; Guan, Xu-Hua; Li, Yu-Hua; Huang, Jian-Ying; Jiang, Tao; Hou, Li-Hua; Li, Jing-Xin; Yang, Bei-Fang; Wang, Ling; Wang, Wen-Juan; Wu, Shi-Po; Wang, Zhao; Wu, Xiao-Hong; Xu, Jun-Jie; Zhang, Zhe; Jia, Si-Yue; Wang, Bu-Sen; Hu, Yi; Liu, Jing-Jing; Zhang, Jun; Qian, Xiao-Ai; Li, Qiong; Pan, Hong-Xing; Jiang, Hu-Dachuan; Deng, Peng; Gou, Jin-Bo; Wang, Xue-Wen; Wang, Xing-Huan; Chen, Wei